CARGO THERAPEUTICS INC (CRGX)
US14179K1016 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 5,894.14% | N/A 264.71% | N/A 44.66% | N/A 51.81% | N/A 65.12% | N/A 26.78% | ||||
| EBITDA YoY % growth | -5.96M | -34.37M -476.68% | -95.219M -177.04% | N/A -104.60% | N/A -50.79% | N/A 2.08% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.98M | -34.77M -481.44% | -96.71M -178.14% | N/A -96.89% | N/A -21.94% | N/A -10.52% | N/A 36.93% | N/A 33.46% | N/A 103.92% | N/A 5,872.74% | N/A 52.66% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 83.22% | N/A -8.90% | N/A 3.37% | N/A 47.07% | N/A 31.67% | N/A 114.63% | N/A 1,804.76% | N/A 55.25% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.03 31.03% | -1.03 -18.18% | -1.02 0.20% | -1.07 -21.94% | -1.13 -9.78% | -1.03 -0.20% | -1.04 -2.20% | -1.12 -4.09% | -0.92 18.63% | -0.97 5.94% | -0.87 16.67% | -0.97 13.24% |
| Revenue Q2Q % growth | 1.02M | 2.04M | 4.08M | N/A | N/A | N/A | ||||||
| EBITDA Q2Q % growth | -55.08M -64.59% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -54.129M -54.85% | -54.016M -32.37% | -55.244M -12.02% | -56.472M -19.87% | -60.142M -11.11% | -56.61M -4.80% | -60.996M -10.41% | -65.688M -16.32% | -70.788M -17.70% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.88 98.14% | -1.15 | 0.27 | 23.75% |
| Q2 2024 Q2Q % growth | -1.02 | -1.05 | 0.03 | 2.64% |
| Q1 2024 Q2Q % growth | -0.87 | -1.07 | 0.20 | 19.02% |
| Q4 2023 Q2Q % growth | -1.49 | -1.47 | -0.02 | -1.21% |
| Q3 2023 Q2Q % growth | -47.37 | -2.84 | -44.53 | -1,568.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 12.28% | 34.58% | 11.62% | 11.62% |
| Revenue | N/A | N/A | N/A | N/A |